Alx Oncology Holdings Inc. · NASDAQ:ALXO
Ra Capital Management, L.P. reported a 9.90% stake in Alx Oncology Holdings Inc. (Schedule 13G)
Event Feb 2, 2026 · Filed Feb 9, 2026
Ra Capital Management, L.P. reported a 9.90% stake in Alx Oncology Holdings Inc., 13,117,106 shares, as a passive investor on Feb 2, 2026. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 13,117,106
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 13,117,106 |
| Peter Kolchinsky | 9.90% | 13,117,106 |
| Rajeev Shah | 9.90% | 13,117,106 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 13,117,106 |
Source
Related
- Alx Oncology Holdings Inc.
- Ra Capital Management, L.P.
- Alx Oncology Holdings Inc. shareholders
- Schedule 13D/A · venBio Global Strategic Fund, L.P. · Oct 16, 2026
- Form 4 · Lettmann Jason · Aug 18, 2026
- Form 4 · Wong Shelly · Aug 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026